EFFECT OF GOKSHURâ??PUNARNAVA BASTI IN DIABETIC NEPHROPATHY

A RANDOMIZED CLINICAL TRIAL ON GOKSHURâ??PUNARNAVA BASTI IN THE MANAGEMENT OF MICROALBUMINURIA IN MADHUMEHA (DIABETES MELLITUS)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2012/03/002496

Enrollment

100

Registered

2012-03-15

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Diabetes with Miocroalbuminuria

Interventions

Intervention1: Gokshura Punarnava Basti: For 8 days 1st and 8th Day Gokshura Punarnava Oil Basti 2nd to 7th day Gokshura Punarnava Kashaya Basti by Anal Route Intervention2: Gokshura Punarnava Basti:

Eligibility

Inclusion criteria

Inclusion criteria: Uncontrolled Diabetic patients Hypertensive patients BP up to 140/90 mm of Hg. Urinary albumin between 30-300mg in 24 Hr. urine sample.

Exclusion criteria

Exclusion criteria: Uncontrolled Hypertensive patients BP more than 140/90 mm of Hg. Microalbuminuria originating due to other diseases except Diabetes mellitus will be excluded. Patients with other severe complications of Diabetes mellitus. Plasma creatinine more than 2.5 mg Any other serious systemic illness. Patients contra indicated for basti.

Design outcomes

Primary

Measure	Time frame
Urinary albumin in 24 Hr. urine sample Biochemical parameters- Renal function test, Blood sugar levels Quality of life assessment scale. Timepoint: 8th day in Trial group and 30th days in Control group	—

Secondary

Measure	Time frame
Not ApplicableTimepoint: Not apllicable	—

Countries

India

Contacts

Public ContactDr Anup B Thakar

Institute for Post Graduate Teaching and Research in Ayurveda

anup_thakar@yahoo.com9427776660

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026